Literature DB >> 28971494

Direct likelihood inference on the cause-specific cumulative incidence function: A flexible parametric regression modelling approach.

Sarwar Islam Mozumder1, Mark Rutherford1, Paul Lambert1,2.   

Abstract

In a competing risks analysis, interest lies in the cause-specific cumulative incidence function (CIF) that can be calculated by either (1) transforming on the cause-specific hazard or (2) through its direct relationship with the subdistribution hazard. We expand on current competing risks methodology from within the flexible parametric survival modelling framework (FPM) and focus on approach (2). This models all cause-specific CIFs simultaneously and is more useful when we look to questions on prognosis. We also extend cure models using a similar approach described by Andersson et al for flexible parametric relative survival models. Using SEER public use colorectal data, we compare and contrast our approach with standard methods such as the Fine & Gray model and show that many useful out-of-sample predictions can be made after modelling the cause-specific CIFs using an FPM approach. Alternative link functions may also be incorporated such as the logit link. Models can also be easily extended for time-dependent effects.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  competing risks; cumulative incidence; flexible parametric; regression; subdistribution hazards; survival analysis

Mesh:

Year:  2017        PMID: 28971494      PMCID: PMC6175037          DOI: 10.1002/sim.7498

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  27 in total

1.  Regression modeling of competing crude failure probabilities.

Authors:  J P Fine
Journal:  Biostatistics       Date:  2001-03       Impact factor: 5.899

2.  Flexible regression models with cubic splines.

Authors:  S Durrleman; R Simon
Journal:  Stat Med       Date:  1989-05       Impact factor: 2.373

3.  Misspecified regression model for the subdistribution hazard of a competing risk.

Authors:  Jan Beyersmann; Martin Schumacher
Journal:  Stat Med       Date:  2007-03-30       Impact factor: 2.373

4.  A competing risks analysis of bloodstream infection after stem-cell transplantation using subdistribution hazards and cause-specific hazards.

Authors:  Jan Beyersmann; Markus Dettenkofer; Hartmut Bertz; Martin Schumacher
Journal:  Stat Med       Date:  2007-12-30       Impact factor: 2.373

5.  Simulating competing risks data in survival analysis.

Authors:  Jan Beyersmann; Aurélien Latouche; Anika Buchholz; Martin Schumacher
Journal:  Stat Med       Date:  2009-03-15       Impact factor: 2.373

Review 6.  A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions.

Authors:  Aurelien Latouche; Arthur Allignol; Jan Beyersmann; Myriam Labopin; Jason P Fine
Journal:  J Clin Epidemiol       Date:  2013-02-14       Impact factor: 6.437

7.  Competing risk regression models for epidemiologic data.

Authors:  Bryan Lau; Stephen R Cole; Stephen J Gange
Journal:  Am J Epidemiol       Date:  2009-06-03       Impact factor: 4.897

8.  The application of cure models in the presence of competing risks: a tool for improved risk communication in population-based cancer patient survival.

Authors:  Sandra Eloranta; Paul C Lambert; Therese M-L Andersson; Magnus Björkholm; Paul W Dickman
Journal:  Epidemiology       Date:  2014-09       Impact factor: 4.822

9.  Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models.

Authors:  Therese M L Andersson; Paul W Dickman; Sandra Eloranta; Paul C Lambert
Journal:  BMC Med Res Methodol       Date:  2011-06-22       Impact factor: 4.615

10.  Flexible parametric modelling of cause-specific hazards to estimate cumulative incidence functions.

Authors:  Sally R Hinchliffe; Paul C Lambert
Journal:  BMC Med Res Methodol       Date:  2013-02-06       Impact factor: 4.615

View more
  8 in total

1.  Time-varying survival effects for squamous cell carcinomas at oropharyngeal and nonoropharyngeal head and neck sites in the United States, 1973-2015.

Authors:  Andrew F Brouwer; Kevin He; Steven B Chinn; Alison M Mondul; Christina H Chapman; Marc D Ryser; Mousumi Banerjee; Marisa C Eisenberg; Rafael Meza; Jeremy M G Taylor
Journal:  Cancer       Date:  2020-09-05       Impact factor: 6.860

Review 2.  A comparison of statistical methods to predict the residual lifetime risk.

Authors:  Sarah C Conner; Alexa Beiser; Emelia J Benjamin; Michael P LaValley; Martin G Larson; Ludovic Trinquart
Journal:  Eur J Epidemiol       Date:  2022-01-03       Impact factor: 8.082

3.  Methods of competing risks flexible parametric modeling for estimation of the risk of the first disease among HIV infected men.

Authors:  Sahar Nouri; Mahmood Mahmoudi; Kazem Mohammad; Mohammad Ali Mansournia; Mahdi Yaseri; Noori Akhtar-Danesh
Journal:  BMC Med Res Methodol       Date:  2020-01-29       Impact factor: 4.615

4.  Lung Cancer Attributed Mortality Among 316,336 Early Stage Breast Cancer Cases Treated by Radiotherapy and/or Chemotherapy, 2000-2015: Evidence From the SEER Database.

Authors:  Semaw Ferede Abera; Rafael T Mikolajczyk; Eva Johanna Kantelhardt; Ljupcho Efremov; Ahmed Bedir; Christian Ostheimer; André Glowka; Dirk Vordermark; Daniel Medenwald
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

5.  Estimating restricted mean survival time and expected life-years lost in the presence of competing risks within flexible parametric survival models.

Authors:  Sarwar I Mozumder; Mark J Rutherford; Paul C Lambert
Journal:  BMC Med Res Methodol       Date:  2021-03-11       Impact factor: 4.615

6.  Establishment of a Competing Risk Nomogram in Patients with Pulmonary Sarcomatoid Carcinoma.

Authors:  Ziwei Liang; Enyu Zhang; Ling Duan; Nathaniel Weygant; Guangyu An; Bin Hu; Jiannan Yao
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

7.  stpm2cr: A flexible parametric competing risks model using a direct likelihood approach for the cause-specific cumulative incidence function.

Authors:  Sarwar Islam Mozumder; Mark J Rutherford; Paul C Lambert
Journal:  Stata J       Date:  2017       Impact factor: 2.637

8.  Direct modeling of the crude probability of cancer death and the number of life years lost due to cancer without the need of cause of death: a pseudo-observation approach in the relative survival setting.

Authors:  Dimitra-Kleio Kipourou; Maja Pohar Perme; Bernard Rachet; Aurelien Belot
Journal:  Biostatistics       Date:  2022-01-13       Impact factor: 5.899

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.